Foundation Medicine to provide Celgene with cancer genomics tests

05/19/2011 | Mass High Tech (Boston)

Foundation Medicine has partnered with Celgene to supply the company with its genetic tests for cancer. Under the deal, Celgene will use the tests to look at the genetic traits of patients enrolled in clinical trials of drugs for various diseases, such as multiple myeloma and prostate cancer.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA